Disparity Matters

Online self-scheduling of breast cancer screening appointments may help reduce disparities in who gets screened.

The University of California at Irvine in 2021 set up an online portal where women could schedule screening that their healthcare provider ordered or that they requested on their own. In all, more than 22,000 women used the portal. Most likely to self-schedule were Hispanic women and women living in the most disadvantaged neighborhoods. Most […]

Online self-scheduling of breast cancer screening appointments may help reduce disparities in who gets screened. Read More »

Women from historically redlined neighborhoods less likely to be screened for breast cancer

Women living in 3,712 redlined U.S. census-tracts, especially in the New York and Los Angeles metropolitan areas, were 24 percent less likely than women living in A (“Best”) areas to meet breast screening targets. Poverty, lack of education and limited English proficiency were among the most significant barriers. See “Historic redlining practices cast a long

Women from historically redlined neighborhoods less likely to be screened for breast cancer Read More »

Residents of historically redlined neighborhoods less likely to be screened for colorectal cancer

Residents of 3,712 redlined U.S. census-tracts, especially in the New York and Los Angeles metropolitan areas, were 64 percent less likely than residents living in A (“Best”) areas to meet colorectal cancer screening targets. Poverty, lack of education and limited English proficiency were among the most significant barriers. See “Historic redlining practices cast a long

Residents of historically redlined neighborhoods less likely to be screened for colorectal cancer Read More »

Women from historically redlined neighborhoods less likely to be screened for cervical cancer

Women living in 3,712 redlined U.S. census-tracts, especially in the New York and Los Angeles metropolitan areas, were 79 percent less likely than women living in A (“Best”) areas to meet cervical cancer screening targets. Poverty, lack of education and limited English proficiency were among the most significant barriers. See “Historic redlining practices cast a

Women from historically redlined neighborhoods less likely to be screened for cervical cancer Read More »

Socioeconomic disadvantages can shorten lifespan of men with early-onset prostate cancer

Men diagnosed with early-onset prostate cancer (at age 55 or younger) are more likely to die sooner if they’re Black, don’t have health insurance, and live in lower-income areas with high levels of people who didn’t finish high school. That’s the finding fromn the first study to investigate how socioeconomic status (SES) affects survival in

Socioeconomic disadvantages can shorten lifespan of men with early-onset prostate cancer Read More »

Black, Hispanic breast cancer patients more likely than Whites to die from second primary cancer

Black and Hispanic female survivors of breast cancer experience higher death rates than White women after being diagnosed with a second primary cancer. In a study of nearly 40,000 adult survivors of breast cancer, the risk of death from a second cancer was 12 percent among Black survivors and 8 percent higher among Hispanic survivors

Black, Hispanic breast cancer patients more likely than Whites to die from second primary cancer Read More »

Black, Hispanic lung cancer patients less likely to get advanced genetic testing, more because they tend to see physicians who don’t do a lot of testing

Blacks and Hispanics are about 8 percent less likely to get timely next-generation genetic sequencing of their lung cancer, less because their physician is treating them differently and more because they tend to see physicians or medical practices that don’t do a lot of genetic testing. That’s the conclusion of a new study of about

Black, Hispanic lung cancer patients less likely to get advanced genetic testing, more because they tend to see physicians who don’t do a lot of testing Read More »

“Surprisingly low rate” of genetic testing in prostate cancer patients, especially in non-Whites

Less than seven percent of cancer patients in California and Georgia underwent genetic testing within two years of diagnosis, despite guidelines recommending genetic testing in the majority of patients. Allison Kurian, MD (above), of the Stanford University Medical School and her colleagues reviewed the records of nearly 1.4 million patients in California and Georgia diagnosed

“Surprisingly low rate” of genetic testing in prostate cancer patients, especially in non-Whites Read More »

“Surprisingly low rate” of genetic testing in female and male breast cancer patients, especially in non-Whites

Less than seven percent of cancer patients in California and Georgia underwent genetic testing within two years of diagnosis, despite guidelines recommending genetic testing in the majority of patients. Allison Kurian, MD (above), of the Stanford University Medical School and her colleagues reviewed the records of nearly 1.4 million patients in California and Georgia diagnosed

“Surprisingly low rate” of genetic testing in female and male breast cancer patients, especially in non-Whites Read More »

“Surprisingly low rate” of genetic testing in colorectal cancer patients, especially in non-Whites

Less than seven percent of cancer patients in California and Georgia underwent genetic testing within two years of diagnosis, despite guidelines recommending genetic testing in the majority of patients. Allison Kurian, MD (above), of the Stanford University Medical School and her colleagues reviewed the records of nearly 1.4 million patients in California and Georgia diagnosed

“Surprisingly low rate” of genetic testing in colorectal cancer patients, especially in non-Whites Read More »

Scroll to Top